Search research articles
Contact Us
Filters
Showing results (61-70 of 107) with videos related to
Page
of 11
Sort By:
Cancers
|
May 16, 2023
Myeloid NGS Analyses of Paired Samples from Bone Marrow and Peripheral Blood Yield Concordant Results: A Prospective Cohort Analysis of the AGMT Study Group
Bettina Jansko-Gadermeir, Michael Leisch, Franz J Gassner, et al.
Cancers
|
February 10, 2021
Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchronous Biopsies
Teresa Magnes, Sandro Wagner, Aaron R Thorner, et al.
Journal of Clinical Medicine
|
June 5, 2020
Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial
Gabriel Rinnerthaler, Simon Peter Gampenrieder, Hubert Hackl, et al.
British Journal of Cancer
|
October 21, 2016
NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients
Katharina T Prochazka, Thomas Melchardt, Florian Posch, et al.
Wiener Klinische Wochenschrift
|
September 16, 2021
Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone : Analysis of the Austrian head and neck cancer registry of the AGMT
Teresa Magnes, Sandro M Wagner, Thomas Melchardt, et al.
European Journal of Haematology
|
February 7, 2019
Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM
Florian Huemer, Thomas Melchardt, Bettina Jansko, et al.
Scientific Reports
|
August 14, 2025
C to U RNA editing of MFN1 is regulated by ADARB1 and associates with favourable prognosis in chronic lymphocytic leukemia
Alejandra Gonzalez Martinez, Franz Josef Gassner, Dominik Baumgartner, et al.
Journal of Clinical Pathology
|
December 9, 2015
The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma
Katharina T Troppan, Thomas Melchardt, Kerstin Wenzl, et al.
European Journal of Haematology
|
February 14, 2015
The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients
Katharina T Troppan, Thomas Melchardt, Alexander Deutsch, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
September 13, 2021
Evaluation of circulating cell-free KRAS mutational status as a molecular monitoring tool in patients with pancreatic cancer
Konstantin Schlick, Steiner Markus, Florian Huemer, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 107) with videos related to
Sort By:
Page
of 11
Cancers
|
May 16, 2023
Myeloid NGS Analyses of Paired Samples from Bone Marrow and Peripheral Blood Yield Concordant Results: A Prospective Cohort Analysis of the AGMT Study Group
Bettina Jansko-Gadermeir, Michael Leisch, Franz J Gassner, et al.
Cancers
|
February 10, 2021
Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchronous Biopsies
Teresa Magnes, Sandro Wagner, Aaron R Thorner, et al.
Journal of Clinical Medicine
|
June 5, 2020
Low Expression of miR-20a-5p Predicts Benefit to Bevacizumab in Metastatic Breast Cancer Patients Treated within the TANIA Phase III Trial
Gabriel Rinnerthaler, Simon Peter Gampenrieder, Hubert Hackl, et al.
British Journal of Cancer
|
October 21, 2016
NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients
Katharina T Prochazka, Thomas Melchardt, Florian Posch, et al.
Wiener Klinische Wochenschrift
|
September 16, 2021
Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone : Analysis of the Austrian head and neck cancer registry of the AGMT
Teresa Magnes, Sandro M Wagner, Thomas Melchardt, et al.
European Journal of Haematology
|
February 7, 2019
Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM
Florian Huemer, Thomas Melchardt, Bettina Jansko, et al.
Scientific Reports
|
August 14, 2025
C to U RNA editing of MFN1 is regulated by ADARB1 and associates with favourable prognosis in chronic lymphocytic leukemia
Alejandra Gonzalez Martinez, Franz Josef Gassner, Dominik Baumgartner, et al.
Journal of Clinical Pathology
|
December 9, 2015
The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma
Katharina T Troppan, Thomas Melchardt, Kerstin Wenzl, et al.
European Journal of Haematology
|
February 14, 2015
The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients
Katharina T Troppan, Thomas Melchardt, Alexander Deutsch, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
September 13, 2021
Evaluation of circulating cell-free KRAS mutational status as a molecular monitoring tool in patients with pancreatic cancer
Konstantin Schlick, Steiner Markus, Florian Huemer, et al.
Page
of 11